Rua Life Sciences Plc announced that following the acquisition of RUA Medical, David Richmond who had been a Non-Executive Director of the Group became Group Chief Executive Officer, with the governance benefits of splitting the role of Chairman and CEO. The Executive Board was also strengthened by the appointment of Dr. Caroline Stretton in January 2021 as Group Chief Operating Officer.